FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?

Up-to-date, several molecular markers of prognosis have been studied in Oral Squamous Cell Carcinoma (OSCC), but none entered in the clinical setting. Therapy of OSCC tumors mainly relies on surgery, radiotherapy and partially on chemotherapy; there is an urgent need for biomarkers able to better st...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Daniela, Merolla, Francesco, Mascolo, Massimo, Ilardi, Gennaro, Romano, Simona, Varricchio, Silvia, Napolitano, Virginia, Celetti, Angela, Postiglione, Loredana, Di Lorenzo, Pier Paolo, Califano, Luigi, Dell’Aversana, Giovanni Orabona, Astarita, Fabio, Romano, Maria Fiammetta, Staibano, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343977/
https://www.ncbi.nlm.nih.gov/pubmed/28218707
http://dx.doi.org/10.3390/ijms18020443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343977/
https://www.ncbi.nlm.nih.gov/pubmed/28218707
http://dx.doi.org/10.3390/ijms18020443

Ejemplares similares